If you are not sure if the website you would like to visit is secure, you can verify it here. Enter the website address of the page and see parts of its content and the thumbnail images on this site. None (if any) dangerous scripts on the referenced page will be executed. Additionally, if the selected site contains subpages, you can verify it (review) in batches containing 5 pages.
favicon.ico: europe.analysisgroup.com/en - Analysis Group Europe.

site address: analysisgroup.com redirected to: europe.analysisgroup.com/en

site title: Analysis Group Europe

Our opinion (on Tuesday 29 September 2026 5:23:51 UTC):

GREEN status (no comments) - no comments
After content analysis of this website we propose the following hashtags:



Meta tags:
description=;

Headings (most frequently used words):

people, the, associated, in, finance, international, antoine, chapsal, expertise, competition, heor, epidemiology, market, access, arbitration, europe, news, events, you, have, jessica, resch, marc, van, audenrode, chris, feige, maja, glowka, emmanuel, frot, tim, giles, marianne, cunnington, philipp, tillmann, joshua, white, weiguang, xue, data, of, economic, across, and, around, world, practices, insights, locations, careers, language, if, economics, or, statistical, challenge, we, solution, meet, our, cases, publications, contact, us, to, find, need, 01, 02, compliance, sustainability, 03, 04, 05, veolia, suez, merger, approval, is, new, oil, non, price, effects, mergers, intensive, industries, steinhoff, holdings, shareholder, litigation, lvmh, moet, hennessy, louis, vuitton, se, acquisition, tiffany, co,

Text of the page (most frequently used words):
and (195), the (122), has (50), competition (45), #international (30), analysis (23), including (22), arbitration (21), economics (19), economic (16), expert (16), group (15), litigation (15), market (15), view (14), finance (14), financial (14), matters (14), for (13), across (13), cases (13), also (13), court (13), global (12), european (12), with (12), chapsal (12), bio (12), his (12), from (11), mergers (11), issues (11), damages (11), valuation (11), read (10), more (10), work (10), access (10), expertise (9), commission (9), white (9), support (9), analyses (9), heor (9), well (9), epidemiology (9), worked (9), been (9), complex (9), research (8), all (8), people (8), provided (8), feige (8), data (8), health (8), experience (8), europe (8), number (8), high (8), compliance (8), world (8), have (8), main (8), our (7), merger (7), law (7), van (7), audenrode (7), industries (7), teams (7), involving (7), specializes (7), strategies (7), pharmaceutical (7), clients (7), range (7), securities (7), back (7), menu (7), experts (6), antitrust (6), regulatory (6), multiple (6), cunnington (6), glowka (6), regularly (6), products (6), profile (6), cartel (6), economist (6), tribunal (6), she (6), real (6), disputes (6), twitter (6), events (5), insights (5), led (5), approval (5), south (5), settlement (5), shareholder (5), tillmann (5), frot (5), veolia (5), giles (5), resch (5), evaluation (5), includes (5), value (5), canada (5), journals (5), policy (5), journal (5), property (5), related (5), supported (5), investigations (5), consulting (5), who (5), econometric (5), trade (5), industry (5), risk (5), post (5), was (5), member (5), claims (5), reports (5), conseil (5), paris (5), accounting (5), sustainability (5), news (4), joshua (4), associated (4), lvmh (4), courts (4), netherlands (4), africa (4), new (4), oil (4), antoine (4), suez (4), services (4), xue (4), cost (4), models (4), jurisdictions (4), published (4), intellectual (4), pricing (4), evidence (4), markets (4), university (4), justice (4), case (4), other (4), safety (4), studies (4), prior (4), joining (4), french (4), france (4), articles (4), firms (4), manipulation (4), testimony (4), academic (4), consultancy (4), cartels (4), explore (4), 2026 (3), find (3), consultants (3), speaks (3), topics (3), acquisition (3), tiffany (3), authorities (3), marc (3), chris (3), years (3), steinhoff (3), philipp (3), price (3), emmanuel (3), behalf (3), review (3), jessica (3), product (3), development (3), areas (3), diseases (3), care (3), strategy (3), assessment (3), medicines (3), wales (3), developed (3), conferences (3), questions (3), authority (3), abuse (3), dominance (3), regulators (3), testifying (3), various (3), served (3), appeal (3), include (3), department (3), managed (3), management (3), context (3), her (3), several (3), positions (3), gsk (3), peer (3), projects (3), board (3), public (3), network (3), software (3), accounts (3), presented (3), appeals (3), commerce (3), before (3), assisted (3), fnac (3), arising (3), dutch (3), provide (3), information (3), which (3), recent (3), quebec (3), germany (3), geographic (3), large (3), regulation (3), careers (3), locations (3), practices (3), privacy (2), use (2), join (2), name (2), first (2), contact (2), you (2), vice (2), president (2), cyril (2), hariton (2), panel (2), lucien (2), frys (2), luxury (2), hennessy (2), louis (2), vuitton (2), countries (2), union (2), negotiation (2), holdings (2), billion (2), non (2), effects (2), agencies (2), weiguang (2), marianne (2), tim (2), maja (2), outcomes (2), extensive (2), budget (2), impact (2), technology (2), national (2), institute (2), scottish (2), north (2), america (2), asia (2), australia (2), japan (2), korea (2), belgium (2), scientific (2), around (2), companies (2), cma (2), involved (2), applying (2), microeconomics (2), sophisticated (2), assessing (2), volume (2), chamber (2), amsterdam (2), chicago (2), such (2), political (2), through (2), federal (2), ftc (2), state (2), econometrics (2), statistical (2), assignments (2), broad (2), over (2), particular (2), design (2), execution (2), marketing (2), innovative (2), pregnancy (2), senior (2), managing (2), private (2), extensively (2), commercial (2), some (2), energy (2), goods (2), testified (2), major (2), forums (2), london (2), counsel (2), galapagos (2), bidco (2), autonomy (2), challenge (2), telecommunications (2), sectors (2), reviewed (2), performed (2), numerous (2), phase (2), horizontal (2), vertical (2), lactalis (2), wide (2), providing (2), gas (2), breach (2), warranty (2), forensic (2), transactions (2), evaluated (2), reporting (2), variety (2), chartered (2), england (2), appointed (2), evaluating (2), share (2), act (2), fsma (2), section (2), 90a (2), analyzing (2), musk (2), alleged (2), foreign (2), exchange (2), analyzed (2), throughout (2), debt (2), arbitrations (2), valuing (2), sovereign (2), labor (2), government (2), executive (2), canadian (2), report (2), equity (2), filed (2), reached (2), largest (2), collective (2), venture (2), capital (2), partner (2), founded (2), mapp (2), brussels (2), based (2), acquired (2), kpmg (2), 2018 (2), previously (2), publishes (2), subjects (2), ranging (2), delineation (2), exclusionary (2), affiliated (2), professor (2), sciences (2), cesifo (2), empirical (2), theoretical (2), industrial (2), organization (2), exchanges (2), abuses (2), dominant (2), quantifications (2), examples (2), lafarge (2), holcim (2), darty (2), airfreight (2), cathode (2), ray (2), tube (2), elevator (2), designing (2), optimized (2), dealing (2), austria (2), higher (2), regional (2), düsseldorf (2), etat (2), constitutionnel (2), english (2), language (2), notices, terms, submit, mailing, list, receive, updates, message, email, last, need, lexology, index, recognizes, thirteen, authors, examine, efficiencies, draft, guidelines, present, ispe, centre, lunch, talk, booking, etraveli, thoughtleaders4, navigating, cross, border, joins, opening, concurrences, hot, proposed, jeweler, moët, team, securing, nine, moet, following, received, shareholders, creditors, cpi, chronicle, january, 2024, intensive, its, environmental, conglomerate, publications, consults, using, inform, launch, decision, making, early, stage, clinical, technologies, therapeutic, oncology, infectious, autoimmune, central, nervous, system, ophthalmology, gynecology, effectiveness, systematic, literature, indirect, treatment, comparison, resource, dossier, successful, hta, submissions, excellence, nice, consortium, smc, awmsg, indications, country, rollouts, supporting, switzerland, zealand, writing, array, enforcement, practice, addressing, cutting, edge, frand, licensing, part, this, technical, front, bodies, supports, denigration, generic, manufacturers, reviews, sika, mbcc, eutelsat, oneweb, coordinated, conduct, specialises, modelling, primarily, follow, overcharge, upstream, downstream, pass, upper, lands, district, holds, appeared, outlets, taught, undergraduate, graduate, students, rochester, cologne, american, science, assists, phases, pre, announcement, investigation, monitoring, merging, parties, doj, attorneys, general, application, methods, witness, witnesses, conducted, epidemiologist, generation, rwe, lifecycle, vaccine, focus, benefit, assessments, focuses, pathways, components, plans, submission, geographies, requirement, commitment, registries, held, within, novartis, glaxosmithkline, chaired, forum, epidemiological, initiative, partnership, building, integrated, monitor, medication, currently, elected, representing, service, providers, society, pharmacoepidemiology, focusing, treaty, engaged, most, covers, pharmaceuticals, mining, manufacturing, hotels, quantum, contentious, restructuring, instructed, assessed, restated, restructurings, yukos, award, saltri, iii, ltd, mezzanine, sicar, lynch, hussain, frank, kebekus, état, highest, administrative, transportation, gambling, prominent, estimated, modeling, implementing, changes, behavior, canal, ocs, cgm, bolloré, logistics, leerdammer, nuova, castelli, aucy, triskalia, nature, découvertes, castel, patriarche, jardiland, invivo, transport, transdev, specialized, quantitative, business, intelligence, advises, concentrations, acted, automotive, consumer, among, others, contractual, transaction, spanned, tracing, funds, fraud, irregularities, allegations, inflating, performance, bonuses, purchase, consideration, under, standard, setting, regimes, generally, accepted, principles, gaap, standards, ifrs, accountants, accountant, dispute, resolution, session, gave, enterprise, regarding, getir, reliance, disclosure, materiality, estimating, counterfactual, prices, false, spam, security, infrastructure, consent, decree, elon, eventually, purchased, initial, offer, ibor, chat, preparing, trial, addition, discounted, cash, flow, asset, backed, collateralized, obligations, securitized, bankruptcy, defaulted, expropriated, fields, retail, operations, class, usa, richard, usher, consulted, developing, methodology, desktop, varied, restaurant, franchises, stock, options, smartphone, features, rent, hydroelectricity, economy, logging, rights, ancestral, territory, nation, area, included, filing, fair, compensation, provincial, judges, prosecutors, advising, pay, recently, between, ageas, claimant, organizations, ever, wcam, coauthor, book, frequent, presenter, mutual, fund, investor, welfare, fortis, developments, project, investments, joint, conflicts, failed, those, relating, funding, arrangements, difficult, operating, environments, periods, crisis, pandemic, disruption, instability, civil, unrest, heightened, founder, firm, arbitral, tribunals, fact, patterns, especially, focused, discounts, premia, derivatives, distressed, assets, meet, regulations, date, deep, knowledge, methodologies, can, their, life, cycles, ranges, illness, adverse, calculations, significant, scale, litigations, insider, trading, are, drawn, offices, help, boards, leadership, embed, governance, considerations, into, corporate, processes, while, sector, dynamics, footprint, each, client, depth, acquisitions, agreements, aid, damage, actions, solution, skip, content,


Text of the page (random words):
gy to value desktop software he also developed expertise valuing goods as varied as restaurant franchises executive stock options or smartphone features his recent work in public economics includes evaluating the economic rent from hydroelectricity to the canadian economy and the value of logging rights on the ancestral territory of a canadian first nation in the area of labor economics his work has included filing an expert report assessing fair compensation for quebec provincial judges and quebec prosecutors and advising quebec s commission on pay equity dr van audenrode has filed expert reports in courts in the us canada belgium germany france and the netherlands and has testified in canada and the us he recently filed a report with the amsterdam court of appeal in support of the settlement reached between ageas and claimant organizations in the fortis case the largest settlement ever reached through the dutch collective settlement act wcam dr van audenrode s scientific research and articles have been published in numerous peer reviewed academic journals and trade journals he is a coauthor of the book the mutual fund industry competition and investor welfare and is a frequent presenter at industry and academic conferences marc van audenrode view bio competition international arbitration finance mr feige specializes in the areas of finance securities and financial markets he has worked on and managed a range of securities and valuation projects in the uk and europe mr feige has been appointed as expert in dutch court to provide valuation and securities claims reports in support of steinhoff s global securities settlement and gave evidence in the dutch enterprise chamber regarding the valuation of getir he has also managed teams evaluating shareholder reliance and disclosure materiality and estimating counterfactual share prices in uk financial services and markets act fsma section 90a litigation matters mr feige has supported experts analyzing the volume of false and spam accounts on twitter twitter s information security infrastructure twitter s data privacy and compliance with a us federal trade commission ftc consent decree and share price and valuation issues on behalf of twitter in twitter v musk in which elon musk eventually purchased twitter at his initial offer price in cases involving alleged market manipulation in the foreign exchange fx and ibor markets he has analyzed trade data and evaluated alleged manipulation strategies mr feige worked on usa v richard usher et al and the foreign exchange class antitrust litigation analyzing fx trade and chat data as well as competition issues preparing experts for testimony at trial and providing data analyses and consulting support to counsel throughout the projects he has also worked on a range of international arbitration cases including valuation damages and competition analyses in addition he has developed complex valuation models including discounted cash flow models and analyzed asset backed securities collateralized debt obligations and other securitized products in support of expert testimony in a number of bankruptcy and damages matters mr feige has also worked on a number of international arbitrations valuing defaulted sovereign debt expropriated oil fields and retail operations his work has been published in several industry journals chris feige view bio finance international arbitration ms glowka is a chartered accountant who specializes in the assessment of damages and forensic analysis arising in the context of dispute resolution she has served as an expert and led consulting teams on complex uk and international assignments including litigation and international arbitration matters in all the major international arbitration forums as well as before the high court of justice in london the scottish court of session and the uk competition appeal tribunal ms glowka has acted on a broad range of litigation and arbitration matters across the automotive oil and gas pharmaceutical telecommunications software and consumer products industries among others her litigation and arbitration work has involved the evaluation of damages arising in the context of contractual and shareholder disputes as well as post transaction disputes such as breach of warranty claims ms glowka s forensic accounting work has spanned analysis and tracing of funds and transactions as well as evaluation of fraud and accounting irregularities including allegations of accounts manipulation for inflating performance related bonuses and purchase consideration she has also evaluated complex financial reporting issues under a variety of accounting standard setting regimes including uk generally accepted accounting principles gaap and international financial reporting standards ifrs ms glowka is a member of the institute of chartered accountants in england and wales maja glowka view bio competition dr frot is an economist with specialized expertise in applying quantitative analyses to competition litigation regulatory and business intelligence issues he advises firms in a wide range of industries providing economic and econometric expertise on matters related to mergers market concentrations cartel investigations and damages over the years he has performed numerous economic and econometric analyses in phase i and phase ii mergers before the french competition authority and the european commission including veolia transport transdev jardiland invivo castel patriarche fnac nature découvertes d aucy triskalia lactalis nuova castelli lactalis leerdammer cma cgm bolloré logistics canal ocs and suez veolia he has led case teams and performed economic analyses in several prominent horizontal and vertical cartel cases as well as estimated damages in antitrust litigation and intellectual property matters he has also assisted companies in modeling and implementing changes to pricing behavior his reports have been presented to the european commission the french competition authority the court of appeals the conseil d état france s highest administrative court the tribunal of commerce of paris and regulators in the telecommunications energy transportation and gambling sectors dr frot has published a number of articles in peer reviewed journals and regularly speaks at international competition law and policy conferences emmanuel frot view bio finance international arbitration mr giles is a financial economist focusing on valuation and financial analysis he has worked extensively in international arbitration including commercial treaty claims and has been engaged in some of the most complex and high profile financial and non financial disputes his experience covers a range of industries across the world including financial services energy pharmaceuticals software luxury goods mining manufacturing property development and hotels mr giles has testified as a quantum expert in all the major international arbitration forums and in a number of high court of justice cases in london in galapagos bidco s à r l v dr frank kebekus et al a contentious financial restructuring he was instructed by counsel for galapagos bidco s à r l mr giles has also assessed the impact of restated accounts on the value of autonomy in hp autonomy v lynch and hussain other restructurings including saltri iii ltd v md mezzanine sa sicar and the challenge to the 50 billion yukos award in the netherlands tim giles view bio heor epidemiology market access dr cunnington has over 20 years of experience as a pharmaceutical industry epidemiologist she specializes in the generation of real world evidence rwe in support of the development and lifecycle management of pharmaceutical and vaccine products with particular focus on regulatory risk management strategies and product benefit risk assessments dr cunnington focuses on regulatory epidemiology with design and execution of real world post marketing safety studies as well as real world studies to support the approval of new products in the context of innovative regulatory pathways her research expertise includes design negotiation and execution of real world components of risk management plans for multiple new product submission with regulators across multiple geographies us uk europe japan south korea post approval safety studies in the eu post marketing requirement and commitment studies in the us and pregnancy registries prior to joining analysis group dr cunnington held several senior epidemiology positions within novartis and glaxosmithkline gsk at gsk she chaired the peer review forum for all pharmaceutical real world evidence projects provided epidemiological expertise for the gsk s global safety board and was a managing board member of the innovative medicines initiative s public private partnership building an integrated european real world data network to monitor medication safety in pregnancy dr cunnington is currently an elected board member representing european industry and service providers for the international society of pharmacoepidemiology marianne cunnington view bio competition dr tillmann is an economist who specializes in the application of microeconomics econometrics and statistical methods to litigation matters investigations and strategy assignments he has served as an expert witness and has supported expert witnesses managed case teams and conducted analyses in merger cartel abuse of dominance and other matters across a broad range of industries and jurisdictions including in the eu the us canada the uk and australia he regularly assists clients across all phases of merger cases from pre announcement through investigation litigation and compliance monitoring his clients include merging parties the us department of justice doj the federal trade commission ftc and state attorneys general dr tillmann holds a ph d in economics from the university of chicago and his research has appeared in outlets such as the journal of competition law economics and the american journal of political science he has taught economics to undergraduate and graduate students at the university of chicago the university of rochester and the university of cologne philipp tillmann view bio competition mr white is a consulting and testifying economist who specialises in applying microeconomics and sophisticated econometric modelling to complex litigation and merger related questions primarily in matters involving the health care financial services and technology industries he has supported clients in various jurisdictions and industries in follow on competition damages litigation assessing overcharge upstream and downstream pass on and volume effects he has served as a testifying expert in the uk upper tribunal lands chamber the uk competition appeal tribunal and the amsterdam district court on competition cases mr white has supported high profile companies with complex merger reviews across multiple jurisdictions including in the veolia suez lvmh tiffany sika mbcc and eutelsat oneweb mergers he has also provided evidence to the uk s competition and markets authority cma and the european commission ec including on behalf of clients involved in cartel investigations abuse of dominance investigations and mergers mr white has also provided support to european financial and competition regulators in coordinated conduct investigations mr white has extensive experience addressing competition and intellectual property ip issues in matters related to cutting edge pharmaceutical products and frand licensing questions as part of this work he has supported a number of scientific and technical experts in front of courts and regulatory bodies he also regularly supports pharmaceutical clients on competition issues around market access pricing denigration and competition from generic manufacturers mr white has worked in a number of jurisdictions including the uk the european union switzerland australia new zealand south africa canada japan korea the netherlands belgium and the us his writing has been published in an array of journals including the journal of european competition law practice the competition law journal and the journal of antitrust enforcement and he regularly speaks at international competition law and policy conferences joshua white view bio heor epidemiology market access mr xue consults on cases involving health economics and outcomes research heor he specializes in using health economics analyses to inform product launch strategies as well as decision making in early stage clinical development mr xue has extensive experience in the economic evaluation of health technologies across multiple therapeutic areas including oncology infectious diseases autoimmune diseases central nervous system diseases ophthalmology and gynecology his work includes cost effectiveness analysis budget impact analysis systematic literature review indirect treatment comparison evaluation of health care resource use global value dossier and market access strategy he has led successful health technology assessment hta submissions to the national institute for health and care excellence nice the scottish medicines consortium smc and the all wales medicines strategy group awmsg he has also developed global economic models across multiple indications and led country rollouts supporting market access in europe north america and asia weiguang xue view bio 1 11 antoine chapsal jessica resch marc van audenrode chris feige maja glowka emmanuel frot tim giles marianne cunnington philipp tillmann joshua white weiguang xue 1 2 find an expert cases publications view all insights competition veolia suez merger approval on behalf of suez in its acquisition by the international environmental services conglomerate veolia analysis group teams provided economic and financial analyses for review by regulatory agencies in multiple countries read more associated people antoine chapsal emmanuel frot lucien frys joshua white competition is data the new oil non price effects of mergers in data intensive industries cpi antitrust chronicle january 2024 read more associated people philipp tillmann finance international arbitration steinhoff international holdings n v shareholder litigation following years of negotiation steinhoff international holdings n v received approval from courts in the netherlands and south africa for a 1 7 billion global settlement with shareholders and creditors read more associated people chris feige marc van audenrode competition lvmh moet hennessy louis vuitton se acquisition of tiffany co for the proposed acquisition of global luxury jeweler tiffany co by lvmh moët hennessy louis vuitton se lvmh an analysis group team led provided economic analysis in support of securing merger approval from competition authorities across nine countries and the european union read more associated people lucien frys joshua white view all insights news events vice president cyril hariton joins opening panel at concurrences global ant...
Thumbnail images (randomly selected): * Images may be subject to copyright.GREEN status (no comments)
  • Analysis Group
  • Antoine Chapsal
  • Jessica Resch
  • Marc Van Audenrode
  • Chris Feige
  • Maja Glowka
  • Emmanuel Frot
  • Tim Giles
  • Marianne Cunnington
  • Philipp Tillmann
  • Joshua White
  • Weiguang Xue
  • Antoine Chapsal
  • Emmanuel Frot
  • Joshua White
  • Philipp Tillmann
  • Chris Feige
  • Marc Van Audenrode

Verified site has: 34 subpage(s). Do you want to verify them? Verify pages:

1-5 6-10 11-15 16-20 21-25 26-30 31-34


The site also has references to the 1 subdomain(s)

  analysisgroup.com  Verify


The site also has 3 references to external domain(s).

 linkedin.com  Verify  bsky.app  Verify  facebook.com  Verify


Top 50 hastags from of all verified websites.

Supplementary Information (add-on for SEO geeks)*- See more on header.verify-www.com

Header

HTTP/1.1 301 Moved Permanently
Date Tue, 29 Sep 2026 05:23:50 GMT
Content-Length 0
Connection close
Location htt????/www.analysisgroup.com/
Server cloudflare
CF-RAY a4288ee09a9d0be4-AMS
alt-svc h3= :443 ; ma=86400
HTTP/2 302
date Tue, 29 Sep 2026 05:23:51 GMT
content-length 0
location htt????/europe.analysisgroup.com/en/
server cloudflare
set-cookie TiPMix=8.615960944029188; path=/; HttpOnly; Domain=www.analysisgroup.com; Max-Age=3600; Secure; SameSite=None
set-cookie x-ms-routing-name=self; path=/; HttpOnly; Domain=www.analysisgroup.com; Max-Age=3600; Secure; SameSite=None
set-cookie ARRAffinity=5ef5a1afbc0178c19fc7bc85047a2309cb69de3271923483302c69744e2b1d24;Path=/;HttpOnly;Secure;Domain=www.analysisgroup.com
set-cookie ARRAffinitySameSite=5ef5a1afbc0178c19fc7bc85047a2309cb69de3271923483302c69744e2b1d24;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.analysisgroup.com
request-context appId=cid-v1:cc0421b6-9549-49c5-a282-0c0cfee96d2c
cf-cache-status DYNAMIC
cf-ray a4288ee1aacaa100-AMS
alt-svc h3= :443 ; ma=86400
HTTP/2 200
date Tue, 29 Sep 2026 05:23:51 GMT
content-type text/html; charset=utf-8
server cloudflare
cache-control no-cache,no-store
expires -1
pragma no-cache
set-cookie TiPMix=17.014443229206012; path=/; HttpOnly; Domain=europe.analysisgroup.com; Max-Age=3600; Secure; SameSite=None
set-cookie x-ms-routing-name=self; path=/; HttpOnly; Domain=europe.analysisgroup.com; Max-Age=3600; Secure; SameSite=None
set-cookie EPiNumberOfVisits=1%2C2026-09-29T05%3A23%3A51; expires=Wed, 29 Sep 2027 05:23:51 GMT; path=/; secure; httponly
set-cookie .AspNetCore.Antiforgery.VyLW6ORzMgk=CfDJ8FCobJqSfnNAhUcdstqa5Yo-25301dOob42wGgI8ImRQINoNprEIWFd9o7jXr52kfVPdxU483F_96zgT9jdjwJuk8N731olu2AvD4BzamnGw1j2zJge2FA-AgQQFUPWlXOa3DISDhQtvEbesfCkD7Xs; path=/; secure; samesite=strict; httponly
set-cookie .AspNetCore.Session=CfDJ8FCobJqSfnNAhUcdstqa5YpoAUXx1rsf29X2qP2UrK9jF6QVCES6A36jcQA18srJWZ2NsGeYHv7PAe%2BpHEFoY%2F4SVwYugVHp3%2BK11MZNYItV6833dR26if%2FJ3C35ETYBjP8c2OLlGnLTlZ11KARtC6KHibnIa%2BcdfSMFwX%2FieG7h; path=/; secure; samesite=lax; httponly
set-cookie ARRAffinity=5ef5a1afbc0178c19fc7bc85047a2309cb69de3271923483302c69744e2b1d24;Path=/;HttpOnly;Secure;Domain=europe.analysisgroup.com
set-cookie ARRAffinitySameSite=5ef5a1afbc0178c19fc7bc85047a2309cb69de3271923483302c69744e2b1d24;Path=/;HttpOnly;SameSite=None;Secure;Domain=europe.analysisgroup.com
request-context appId=cid-v1:cc0421b6-9549-49c5-a282-0c0cfee96d2c
content-security-policy default-src self ; script-src unsafe-inline unsafe-eval self htt????/www.google.com/ htt????/www.google-analytics.com htt????/www.gstatic.com/ htt????/player.vimeo.com/ htt????/*.googletagmanager.com/ htt????/tagmanager.google.com/ htt????/*.youtube.com htt????/www.googleadservices.com htt????/pagead2.googlesyndication.com htt????/googleads.g.doubleclick.net/ htt????/ad.doubleclick.net/ htt????/ade.googlesyndication.com/ htt????/adservice.google.com/ htt????/cmp.osano.com htt????/marvel-b2-cdn.bc0a.com htt????/cdn.b0e8.com htt????/use.typekit.net htt????/cdn.jsdelivr.net htt????/code.jquery.com htt????/js.monitor.azure.com htt????/dc.services.visualstudio.com htt????/maps.googleapis.com htt????/www.gstatic.com htt????/e.infogram.com htt????/public.tableau.com htt????/*.osano.com; style-src unsafe-inline self htt????/stackpath.bootstrapcdn.com htt????/use.fontawesome.com htt????/fonts.googleapis.com/ htt????/googletagmanager.com/ htt????/tagmanager.google.com/ htt????/cdn.jsdelivr.net htt????/*.typekit.net htt????/*.osano.com; object-src none ; base-uri self ; connect-src self htt????/vimeo.com htt????/*.vimeo.com htt????/*.google-analytics.com htt???/*.googletagmanager.com htt????/*.analytics.google.com htt????/*.g.doubleclick.net htt????/*.google.com htt????/pagead2.googlesyndication.com htt????/www.googleadservices.com htt????/googleads.g.doubleclick.net/ htt????/*.google.ad htt????/*.google.ae htt????/*.google.com.af htt????/*.google.com.ag htt????/*.google.al htt????/*.google.am htt????/*.google.co.ao htt????/*.google.com.ar htt????/*.google.as htt????/*.google.at htt????/*.google.com.au htt????/*.google.az htt????/*.google.ba htt????/*.google.com.bd htt????/*.google.be htt????/*.google.bf htt????/*.google.bg htt????/*.google.com.bh htt????/*.google.bi htt????/*.google.bj htt????/*.google.com.bn htt????/*.google.com.bo htt????/*.google.com.br htt????/*.google.bs htt????/*.google.bt htt????/*.google.co.bw htt????/*.google.by htt????/*.google.com.bz htt????/*.google.ca htt????/*.google.cd htt????/*.google.cf htt????/*.google.cg htt????/*.google.ch htt????/*.google.ci htt????/*.google.co.ck htt????/*.google.cl htt????/*.google.cm htt????/*.google.cn htt????/*.google.com.co htt????/*.google.co.cr htt????/*.google.com.cu htt????/*.google.cv htt????/*.google.com.cy htt????/*.google.cz htt????/*.google.de htt????/*.google.dj htt????/*.google.dk htt????/*.google.dm htt????/*.google.com.do htt????/*.google.dz htt????/*.google.com.ec htt????/*.google.ee htt????/*.google.com.eg htt????/*.google.es htt????/*.google.com.et htt????/*.google.fi htt????/*.google.com.fj htt????/*.google.fm htt????/*.google.fr htt????/*.google.ga htt????/*.google.ge htt????/*.google.gg htt????/*.google.com.gh htt????/*.google.com.gi htt????/*.google.gl htt????/*.google.gm htt????/*.google.gr htt????/*.google.com.gt htt????/*.google.gy htt????/*.google.com.hk htt????/*.google.hn htt????/*.google.hr htt????/*.google.ht htt????/*.google.hu htt????/*.google.co.id htt????/*.google.ie htt????/*.google.co.il htt????/*.google.im htt????/*.google.co.in htt????/*.google.iq htt????/*.google.is htt????/*.google.it htt????/*.google.je htt????/*.google.com.jm htt????/*.google.jo htt????/*.google.co.jp htt????/*.google.co.ke htt????/*.google.com.kh htt????/*.google.ki htt????/*.google.kg htt????/*.google.co.kr htt????/*.google.com.kw htt????/*.google.kz htt????/*.google.la htt????/*.google.com.lb htt????/*.google.li htt????/*.google.lk htt????/*.google.co.ls htt????/*.google.lt htt????/*.google.lu htt????/*.google.lv htt????/*.google.com.ly htt????/*.google.co.ma htt????/*.google.md htt????/*.google.me htt????/*.google.mg htt????/*.google.mk htt????/*.google.ml htt????/*.google.com.mm htt????/*.google.mn htt????/*.google.com.mt htt????/*.google.mu htt????/*.google.mv htt????/*.google.mw htt????/*.google.com.mx htt????/*.google.com.my htt????/*.google.co.mz htt????/*.google.com.na htt????/*.google.com.ng htt????/*.google.com.ni htt????/*.google.ne htt????/*.google.nl htt????/*.google.no htt????/*.google.com.np htt????/*.google.nr htt????/*.google.nu htt????/*.google.co.nz htt????/*.google.com.om htt????/*.google.com.pa htt????/*.google.com.pe htt????/*.google.com.pg htt????/*.google.com.ph htt????/*.google.com.pk htt????/*.google.pl htt????/*.google.pn htt????/*.google.com.pr htt????/*.google.ps htt????/*.google.pt htt????/*.google.com.py htt????/*.google.com.qa htt????/*.google.ro htt????/*.google.ru htt????/*.google.rw htt????/*.google.com.sa htt????/*.google.com.sb htt????/*.google.sc htt????/*.google.se htt????/*.google.com.sg htt????/*.google.sh htt????/*.google.si htt????/*.google.sk htt????/*.google.com.sl htt????/*.google.sn htt????/*.google.so htt????/*.google.sm htt????/*.google.sr htt????/*.google.st htt????/*.google.com.sv htt????/*.google.td htt????/*.google.tg htt????/*.google.co.th htt????/*.google.com.tj htt????/*.google.tl htt????/*.google.tm htt????/*.google.tn htt????/*.google.to htt????/*.google.com.tr htt????/*.google.tt htt????/*.google.com.tw htt????/*.google.co.tz htt????/*.google.com.ua htt????/*.google.co.ug htt????/*.google.co.uk htt????/*.google.com.uy htt????/*.google.co.uz htt????/*.google.com.vc htt????/*.google.co.ve htt????/*.google.co.vi htt????/*.google.com.vn htt????/*.google.vu htt????/*.google.ws htt????/*.google.rs htt????/*.google.co.za htt????/*.google.co.zm htt????/*.google.co.zw htt????/*.google.cat htt???/localhost:58847 ws://localhost:58847 wss://localhost:44390 htt????/dc.services.visualstudio.com htt????/maps.googleapis.com htt????/*.in.applicationinsights.azure.com htt????/*.org.coveo.com htt????/use.typekit.net htt????/*.osano.com htt????/js.monitor.azure.com; font-src self htt????/fonts.gstatic.com data: htt????/use.fontawesome.com htt????/use.typekit.net; frame-src self htt????/www.google.com/ htt????/*.vimeo.com htt????/*.youtube.com htt???/www.googletagmanager.com htt????/*.doubleclick.net htt????/www.facebook.com htt????/analysisgroupfiles.com htt????/e.infogram.com htt????/public.tableau.com htt????/*.osano.com; img-src self blob: data: htt???/*.googletagmanager.com/ htt????/*.gstatic.com/ htt????/*.google-analytics.com/ htt????/*.analytics.google.com htt????/*.g.doubleclick.net htt????/*.google.com htt????/pagead2.googlesyndication.com htt????/ad.doubleclick.net/ htt????/googleads.g.doubleclick.net/ htt????/google.com/ htt????/ade.googlesyndication.com/ htt????/*.google.ad htt????/*.google.ae htt????/*.google.com.af htt????/*.google.com.ag htt????/*.google.al htt????/*.google.am htt????/*.google.co.ao htt????/*.google.com.ar htt????/*.google.as htt????/*.google.at htt????/*.google.com.au htt????/*.google.az htt????/*.google.ba htt????/*.google.com.bd htt????/*.google.be htt????/*.google.bf htt????/*.google.bg htt????/*.google.com.bh htt????/*.google.bi htt????/*.google.bj htt????/*.google.com.bn htt????/*.google.com.bo htt????/*.google.com.br htt????/*.google.bs htt????/*.google.bt htt????/*.google.co.bw htt????/*.google.by htt????/*.google.com.bz htt????/*.google.ca htt????/*.google.cd htt????/*.google.cf htt????/*.google.cg htt????/*.google.ch htt????/*.google.ci htt????/*.google.co.ck htt????/*.google.cl htt????/*.google.cm htt????/*.google.cn htt????/*.google.com.co htt????/*.google.co.cr htt????/*.google.com.cu htt????/*.google.cv htt????/*.google.com.cy htt????/*.google.cz htt????/*.google.de htt????/*.google.dj htt????/*.google.dk htt????/*.google.dm htt????/*.google.com.do htt????/*.google.dz htt????/*.google.com.ec htt????/*.google.ee htt????/*.google.com.eg htt????/*.google.es htt????/*.google.com.et htt????/*.google.fi htt????/*.google.com.fj htt????/*.google.fm htt????/*.google.fr htt????/*.google.ga htt????/*.google.ge htt????/*.google.gg htt????/*.google.com.gh htt????/*.google.com.gi htt????/*.google.gl htt????/*.google.gm htt????/*.google.gr htt????/*.google.com.gt htt????/*.google.gy htt????/*.google.com.hk htt????/*.google.hn htt????/*.google.hr htt????/*.google.ht htt????/*.google.hu htt????/*.google.co.id htt????/*.google.ie htt????/*.google.co.il htt????/*.google.im htt????/*.google.co.in htt????/*.google.iq htt????/*.google.is htt????/*.google.it htt????/*.google.je htt????/*.google.com.jm htt????/*.google.jo htt????/*.google.co.jp htt????/*.google.co.ke htt????/*.google.com.kh htt????/*.google.ki htt????/*.google.kg htt????/*.google.co.kr htt????/*.google.com.kw htt????/*.google.kz htt????/*.google.la htt????/*.google.com.lb htt????/*.google.li htt????/*.google.lk htt????/*.google.co.ls htt????/*.google.lt htt????/*.google.lu htt????/*.google.lv htt????/*.google.com.ly htt????/*.google.co.ma htt????/*.google.md htt????/*.google.me htt????/*.google.mg htt????/*.google.mk htt????/*.google.ml htt????/*.google.com.mm htt????/*.google.mn htt????/*.google.com.mt htt????/*.google.mu htt????/*.google.mv htt????/*.google.mw htt????/*.google.com.mx htt????/*.google.com.my htt????/*.google.co.mz htt????/*.google.com.na htt????/*.google.com.ng htt????/*.google.com.ni htt????/*.google.ne htt????/*.google.nl htt????/*.google.no htt????/*.google.com.np htt????/*.google.nr htt????/*.google.nu htt????/*.google.co.nz htt????/*.google.com.om htt????/*.google.com.pa htt????/*.google.com.pe htt????/*.google.com.pg htt????/*.google.com.ph htt????/*.google.com.pk htt????/*.google.pl htt????/*.google.pn htt????/*.google.com.pr htt????/*.google.ps htt????/*.google.pt htt????/*.google.com.py htt????/*.google.com.qa htt????/*.google.ro htt????/*.google.ru htt????/*.google.rw htt????/*.google.com.sa htt????/*.google.com.sb htt????/*.google.sc htt????/*.google.se htt????/*.google.com.sg htt????/*.google.sh htt????/*.google.si htt????/*.google.sk htt????/*.google.com.sl htt????/*.google.sn htt????/*.google.so htt????/*.google.sm htt????/*.google.sr htt????/*.google.st htt????/*.google.com.sv htt????/*.google.td htt????/*.google.tg htt????/*.google.co.th htt????/*.google.com.tj htt????/*.google.tl htt????/*.google.tm htt????/*.google.tn htt????/*.google.to htt????/*.google.com.tr htt????/*.google.tt htt????/*.google.com.tw htt????/*.google.co.tz htt????/*.google.com.ua htt????/*.google.co.ug htt????/*.google.co.uk htt????/*.google.com.uy htt????/*.google.co.uz htt????/*.google.com.vc htt????/*.google.co.ve htt????/*.google.co.vi htt????/*.google.com.vn htt????/*.google.vu htt????/*.google.ws htt????/*.google.rs htt????/*.google.co.za htt????/*.google.co.zm htt????/*.google.co.zw htt????/*.google.cat htt????/analysis-group.vuture.net htt????/a1.b0e8.com htt????/p.typekit.net htt????/marvel-b1-cdn.bc0a.com htt????/maps.googleapis.com htt????/marvel-processor.bc0a.com; manifest-src self ; media-src self ; worker-src blob: htt????/*.osano.com; form-action self ; upgrade-insecure-requests;block-all-mixed-content;
cf-cache-status DYNAMIC
content-encoding gzip
cf-ray a4288ee47c13f850-CDG
alt-svc h3= :443 ; ma=86400

Meta Tags

title="Analysis Group Europe"
charset="UTF-8"
http-equiv="X-UA-Compatible" content="IE=edge"
name="viewport" content="width=device-width, initial-scale=1"
name="description" content=""
property="og:url" content="htt????/europe.analysisgroup.com/en/"
property="og:image" content="/Resources/images/og_logo.png"
property="og:type" content="article"
property="og:title" content="AG Europe"
property="og:description" content=""
name="be:sdk" content="dotnet_sdk_1.4.23"
name="be:timer" content="8ms"
name="be:orig_url" content="https%3a%2f%2feurope.analysisgroup.com%2fen%2f"
name="be:capsule_url" content="https%3a%2f%2fixfd1-api.bc0a.com%2fapi%2fixf%2f1.0.0%2fget_capsule%2ff00000000166018%2f02021519280"
name="be:norm_url" content="https%3a%2f%2feurope.analysisgroup.com%2fen%2f"
name="be:api_dt" content="py_2025; pm_07; pd_17; ph_16; pmh_03; p_epoch:1752793420097"
name="be:mod_dt" content="py_2025; pm_07; pd_17; ph_16; pmh_03; p_epoch:1752793420097"
name="be:messages" content="0"
name="contenttype" content="undefined"
name="displaycontenttype" content="undefined"
name="pagesummary"
name="pagename" content="Europe"
name="pagelanguage" content="en"
name="pagecreateddate" content="2025-04-22T19:49:14"
name="pagemodifieddate" content="2025-07-30T21:34:43"
name="hidefromsearch" content="1"

Load Info

page size28860
load time (s)0.936399
redirect count2
speed download30833
server IP 104.17.50.192
* all occurrences of the string "http://" have been changed to "htt???/"